Skip to main content
Cureus logoLink to Cureus
. 2023 Dec 2;15(12):e49853. doi: 10.7759/cureus.49853

Comparing the Efficacy of Povidone-Iodine Versus Normal Saline in Laparotomy Wound Irrigation to Prevent Surgical Site Infections: A Meta-Analysis

Christie Swaminathan 1, Wei H Toh 1, Ahmed Mohamed 2,, Hussameldin M Nour 3, Mirza Baig 4, Muhammad Sajid 1
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10758658  PMID: 38169675

Abstract

Surgical site infections (SSIs) are a known complication of laparotomies and intra-abdominal surgical operations leading to remarkable consequences on mortality, morbidity, and expenses. The study aims to assess the efficiency of irrigating laparotomy incision sites with povidone-iodine (PVI) or normal saline (NS) in diminishing the rate of SSIs in patients undergoing gastrointestinal operations for varying indications.

Randomized controlled trials (RCTs) highlighting the contribution of laparotomy wound irrigation with PVI in opposition to NS in patients planned for laparotomy addressing numerous gastrointestinal issues, and their role in reducing SSI risk were obtained via searching of standard electronic medical databases. The analysis was conducted by utilizing meta-analysis principles procured by statistical software RevMan version 5.3 (Cochrane Collaboration, London, UK).

The yield of medical databases exploration and inspection was 13 RCTs on 3816 patients who underwent laparotomy for different gastrointestinal operations. There were 1900 patients in the PVI group whereas 1916 patients received NS wound irrigations preceding closure of the laparotomy skin wound. In the random effects model analysis, the use of PVI for laparotomy wound irrigation was associated with the reduced risk (odds ratio = 0.54, 95% CI (0.30, 0.98), Z = 2.04, P = 0.04) of SSIs. Nevertheless, there was outstanding heterogeneity (Tau2 = 70; chi2 = 40.19, df = 12; P = 0.0001; I2 = 70%) among the included studies.

According to the comprehensive analysis outcomes, it has been clinically proven that the use of PVI is highly effective in reducing the occurrence of SSIs, as well as their subsequent implications.

Keywords: meta-analysis, wound irrigation, surgical site infection, laparotomy, povidone-iodine

Introduction and background

Surgical site infections (SSIs) are surgical complications leading to profound hardship in postoperative surgical patients manifested as extended intravenous or oral antibiotics use, lengthy wound care and hospital stay, and repeated radiological and surgical interventions [1]. As a result, SSIs account for an additional financial burden on healthcare systems worldwide. Furthermore, SSIs can cause delays in returning to normal work and suboptimal health-related quality of life of patients resulting in secondary loss of finances and dependence on long-term social support. Intra-abdominal sepsis following colorectal surgery and small bowel resection surgery leading to stoma formation, which adds significant financial burden, is a prime example.

In the UK, in 2021-2022, the incidence of SSIs reported amounted to 7.9% and 7.3% following large bowel and small bowel surgery, respectively [2]. In the USA, an incidence of 0.5% to 3% of SSIs across all surgical specialties has been documented [3]. There has been inconsistent SSI reporting data from Europe, with SSI incidence fluctuating between 1.5% and 20%. Moreover, SSI incidence of 14.4% and 20.0% in middle and low-income countries, respectively, was noted [4]. The overburden to manage post-operative infective complications was gauged to be between 1.47 billion and 19.1 billion euros [5]. Comparatively, it has been estimated that the cost of SSI management in the NHS can be $700 million, whereas in the USA, it can be approximately $3.3 billion annually [6,7].

Reduction in the aforementioned financial burden is achievable by implementing several diverse, yet effective measures [8]. These measures to lessen the incidence of SSI have been suggested and can be subdivided into three categories: pre-operative, intra-operative, and post-operative measures [9]. Pre-operative use of prophylactic antibiotics and sterile wound drapes in a number of operations illustrated profitable improvement by reducing the SSI incidence [10,11]. Various irrigation solutions have been used intra-operatively, including contrasting concentrations of povidone-iodine (PVI) and saline that were proven effective in reducing the incidence of SSIs [12-14]. In the context of digestive system disease surgeries, intra-peritoneal lavage is often considered a rational step, performed following colorectal or small bowel resections with the intent to reduce the emergence of SSIs [15]. A noteworthy opposing opinion is that intra-abdominal lavage in the context of emergency trauma laparotomy may not be as effective in tapering down the incidence of SSIs [16]. Laparotomy wound irrigation by various solutions such as antibiotics solution, normal saline (NS) solution, water solution, PVI, and chlorhexidine solution have also been attributed to reducing the incidence of SSIs. Both PVI and NS for wound irrigation have been reported to be helpful in preventing SSIs, but there does not seem to be solid evidence in the literature to suggest that a single agent surpasses the other [17,18].

If the efficacy of PVI resembles that of NS, then NS would instinctively be the preferred wound irrigation in terms of cost-effectiveness. The objective of this study, which was presented as an abstract in the Annual Congress of the Association of Surgeons of Great Britain and Ireland on 17-19 May 2023, is to evaluate the role of laparotomy wound irrigation either by PVI or NS in patients undergoing gastrointestinal laparotomy and assess their role in reducing the incidence of SSIs.

It is noteworthy to mention that numerous healthcare organizations and institutes across the globe have been suggesting and promoting measures to reduce SSI incidence as they proved their burden.

Review

Guidelines

This work has been reported under AMSTAR (Assessment of Multiple Systematic Reviews) and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and a PRISMA flowchart has been created and included in line with the PRISMA guidelines.

Literature exploration and data basis

The standard electronic databases such as MEDLINE, Embase, and Cochrane Library for all the published randomized controlled trials (RCTs) were navigated to locate the appropriate studies included in this meta-analysis. The Medical Subject Heading (MeSH) search terms (surgical site infection, SSI, laparotomy, wound irrigation, povidone-iodine wound wash, saline wound wash, large bowel resection, small bowel resection, etc.) given in the MEDLINE library related to the target objective were used to narrow down the relevant RCTs. In this search, no limitations were set on language, gender, number of recruited patients in the reported trial, or place of study origin. In addition, the Boolean operators (AND, OR, NOT) were also incorporated at relevant places in the search engines to both narrow and widen the range of results. The published titles encountered were carefully reviewed and assessed for potential inclusion or exclusion from the study. Furthermore, the references from selected studies were utilized as an additional search strategy to find extra trials (Figure 1).

Figure 1. PRISMA flow chart showing literature search strategy and trial selection.

Figure 1

PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Eligibility criteria

All RCTs had to compare the risk of post-operative SSIs in patients undergoing laparotomy for extended types of general, colorectal, upper gastrointestinal, hepato-biliary, or pancreatic surgery. Included RCTs should have compared laparotomy wound irrigation by PVI versus NS.

Data acquirement

Data reported in the encompassed RCTs were acquired by two distinct authors on a predefined meta-analysis data extraction form. The item was compared and discovered to have a reasonable level of agreement among the reviewers. The procured data consisted of a list of authors, title of the published study, journal of publication, country and year of the publication, testing sample size (with sex differentiation when applicable), the number of patients in each group, treatment protocol for each intervention, post-operative SSIs, and duration of follow up. Following final data extraction, a meticulous discussion took part between the independent reviewers and, if any contrasts were found, a mutual agreement was negotiated.

Evidence procurement

For statistical exploration and calculations, the software package RevMan provided by the Cochrane Collaboration (London, UK) was used [19,20]. The odds ratio (OR) with a 95% confidence interval (CI) was implemented to outline the combined outcome for binary data on the incidence of post-operative SSIs. The calibration of the combined outcome was made possible by applying the random-effects model [21,22]. Heterogeneity among included studies was explored using the chi2 test, with significance set at p < 0.05, and was quantified [23] using the I2 test with a maximum value of 30% identifying low heterogeneity [23], 30%-60% identifying a moderate heterogeneity, and more than 90% set as significantly high heterogeneity. The Mantel-Haenszel method was used for calculating OR under the random effect model analysis [24]. In a sensitivity analysis, 0.5 was added to each cell frequency for trials in which an event had taken a course in neither the treatment nor control group, according to the recommended method by Deeks et al. [25]. The Cochrane Collaboration calculation guidelines were resorted to in events where the standard deviation was not obtainable [21]. This involved assumptions that both groups had the same variance, which may not be factual, and variance was estimated from either the range or p-value. The pooled estimated difference was calculated based on each trial estimate variance's effect weights. A forest plot was used for the graphical exhibition of the results. The square around the estimate signified the accuracy of the estimation (sample size), while the horizontal line represented the 95% CI. The methodological quality of the included trials underwent evaluation in line with the standards of the Cochrane Collaboration in addition to the guidelines of Jaddad et al., Chalmers et al., and Rangel et al. [26-28].

Endpoint

The prime endpoint in this meta-analysis comparing laparotomy wound irrigation by PVI vs. NS in abdominal surgery patients was reached by examining the post-operative SSIs.

Outcome

Standard medical databases search generated 78 potential studies. Supplemental sources such as reviewing the bibliography of the published trials also contributed to three further studies that could be included in this review. The titles and abstracts of 78 studies were skimmed, and 55 studies were considered irrelevant. The remaining 23 studies were thoroughly examined and brought down to 13 studies that proved eligible to be included in the systematic review (Figure 1).

Quantitative Involved Trials Review

The 13 RCTs [29-41] involving 3816 patients fulfilled the inclusion criteria for the meta-analysis conducted per the principles of the Cochrane Collaboration. The PRISMA flow chart in trial search, deletion and selection, and study inclusion is presented in Figure 1. Although the inclusion criteria in the reviewed trials slightly differed, laparotomy wound irrigation by PVI and subsequent SSI condition as the primary outcome was homogenous among all studies. The number of recruited patients in the trials varied from 116 [33] to 941 [36] and the weighted percentage contributed by each trial to generate a summated evidence varied from 0.16% [34] to 2.87% [33]. Culminated evidence derived from the database search displayed that trials on this particular matter were being conducted for at least 43 years, spanning from 1979 [39] to 2022 [36], leading us to believe in the ongoing interest in finding the role of PVI in SSIs prevention. Follow-up duration for the included RCTs wavered between seven and 120 days. The panel of recruited patients extended beyond individuals undergoing laparotomy for general, colorectal, upper gastrointestinal, hepato-biliary, and pancreatic surgery, to ones with pelvic, gynecological, and oncological indications.

Qualitative Involved Trials Review

The methodological quality of the included trials was determined by covering quality indicators, namely, randomization technique, blinding, concealment, power calculations, intention-to-treat analysis, trial registration, and ethics committee approval. These indicators were evaluated by using the GRADEpro tool and other tools [26-28] and summary evidence was generated (Table 1).

Table 1. GRADEpro summary of evidence.

Patient or population: Patients attempted for surgical site infection (SSI) prevention. Intervention: Povidone-iodine laparotomy wound irrigation. Comparison: Saline.

Grade working group grades of evidence:- High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.

* The basis of the assumed risk (e.g., the median control group risk across studies) is provided in the footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

Povidone-iodine laparotomy wound irrigation compared to saline for prevention of surgical site infection
Outcomes Illustrative comparative risks* (95% CI) Relative effect (95% CI) No. of participants (studies) Quality of the evidence (grade) Comments
Assumed risk Corresponding risk
Saline Povidone iodine laparotomy wound irrigation
SSI odds ratio. Follow-up: mean six weeks Study population OR = 0.54 (0.3 to 0.98) 3816 (13 studies) High quality -
79 per 1000 44 per 1000 (25 to 78)
Moderate  
  46 per 1000 (26 to 80)

Analysis of the Primary Outcome Measure

The individual OR and summated OR with 95% CIs analyzed using the random effects model meta-analysis of included RCTs are presented in Figure 2. Consequently, in the random effects model analysis, the incidence of SSIs was statistically lower in PVI (OR = 0.54, 95% CI (0.30, 0.98), Z = 2.03, p = 0.04). However, significant statistical heterogeneity (Tau2 = 0.70; chi2 = 40.19; df = 12; I2 = 70%; p = 0.0001) was also observed between the included trials.

Figure 2. Forest plot showing the incidence of surgical site infections. The odds ratios are shown with 95% confidence intervals.

Figure 2

Baker et al. (1994) [29], Chang et al. (2006) [30], Cheng et al. (2005) [31], Karuserci et al. (2019) [32], Kashtel et al. (2020) [33], Kokavec et al. (2008) [34], Lau et al. (1986) [35], Maemoto et al. (2023) [36], Owais et al. (2019) [37], Rogers et al. (1983) [38], Sindelar et al. (1979) [39], Sindelar et al. (1985) [40], Zhao et al. (2023) [41].

Discussion

Evidence Briefing

Founded upon inspecting 13 RCTs on 3816 patients undergoing laparotomy for abundant reasons, PVI, as a wound irrigation solution, consolidated its advantage in reducing SSI risk. Hence, it would routinely be considered for laparotomy wound irrigation as a reducing measure of the functional and financial impact of SSI management.

Evidence Validity

The included studies report an assorted range of surgery types, which could be subdivided depending on laparotomy wounds into four categories: clean, clean-contaminated, contaminated, and dirty wounds. Therefore, concluding that the generated evidence is universally applicable is difficult. An appreciable number of trials focused on gynecological patients, impacting the generalizability of the results to all surgical patients. The number of recruited patients varied from 116 to 941, and each trial's contribution to the accumulated evidence ranged from 0.16% to 2.87%. The evidence indicates that trials on this subject have been conducted for at least 43 years, from 1979 to 2022. This highlights significant differences between participants and surgical techniques, while developing antibiotic resistance over time may also affect the results.

Evidence Quality

Based on the evaluation of the reported quality indicators and screening through the Cochrane tool for bias risk, and the GRADEpro tool (Table 1), the presented evidence may be labeled as adequate. However, on the background of study limitations, a degree of partiality was observed due to statistical heterogeneity besides methodological diversity seen in the inclusion criteria of included RCTs. As PVI wound irrigation is both cost-effective and time-saving, it could go without saying that its routine use may be recommenced.

Contrasting Reviews

Mueller et al. [17] reported a meta-analysis on 41 RCTs recruiting patients over 9000, which showed that intra-operative wound irrigation by any solution was associated with a reduced incidence of SSIs compared to no irrigation. Further subgroup analysis showed that the effect of reduced SSI incidence was strongest in colorectal surgery when wounds were irrigated with antibiotic solutions, in comparison with PVI or saline irrigation. However, according to the quality assessment, all of the included cases were at notable bias risk. The current study evaluated the effect of PVI solely on all patients undergoing laparotomy for gastrointestinal and gynecological pathologies, and it is the largest study up to today, favoring the routine use of PVI wound irrigation to reduce SSIs incidence. De Jonge et al. [42] reported the data on 21 studies suggesting a low quality of evidence, demonstrating a statistically significant benefit of incisional wound irrigation with PVI in clean and clean-contaminated wounds, in addition to refuting the role of antibiotic irrigation in reducing SSIs. The conclusion of the study reported that low-quality evidence existed in using prophylactic incisional wound irrigation to prevent SSIs with an aqueous PVI solution, in addition to displaying insensible antibiotic irrigation use. This study reported a combined analysis of trials evaluating the role of wound irrigation with saline versus antibiotics solution resulting in misleading outcomes. The current study reports the evaluation of PVI's prophylactic role in reducing SSIs, which has demonstrated superiority over normal saline or nothing. Fu et al. [43] reported a meta-analysis of 24 studies on 4967 subjects evaluating antibiotic solution irrigation, aqueous PVI, and saline irrigation. Again, it supported the use of PVI wound irrigation to reduce SSI incidence. The findings of our study are in concordance with the previously published three reviews.

Limitations

Several limitations of this study came into sight, particularly, the significant heterogeneity among included studies accounting for a degree of bias. It indicates diverse inclusion and exclusion criteria, and combined analysis of studies recruiting patients undergoing procedures with clean, clean-contaminated, and contaminated wounds resulting in outcomes with hard-to-overlook bias. Although this is the largest study recorded reporting the role of PVI-based laparotomy wound irrigation in reducing SSIs, the conclusion should still be interpreted cautiously due to these several limitations.

Implications

Putting RCTs evaluating the role of PVI in clean-contaminated or grossly contaminated into consideration is a must since this group presents with the highest incidence of SSIs. Equal consideration should be paid to trials focusing on upper gastrointestinal resections versus lower gastrointestinal resections to assess where PVI wound irrigation would be deemed beneficial. Likewise, the role of PVI wound irrigation after laparoscopic colorectal or gastric resections may also be explored.

Conclusions

After conducting a thorough review of multiple research studies on suitable wound irrigation solutions for laparotomy surgeries over the past few decades, it has been observed that PVI is the most effective in reducing the risk of SSIs. Additionally, using PVI has financial benefits as it helps limit expenses related to re-operation, and extended courses of antibiotics, and ultimately results in improved quality of life for patients.

The authors have declared that no competing interests exist.

Author Contributions

Acquisition, analysis, or interpretation of data:  Ahmed Mohamed, Muhammad Sajid, Mirza Baig

Drafting of the manuscript:  Ahmed Mohamed, Muhammad Sajid

Concept and design:  Christie Swaminathan, Wei H. Toh, Hussameldin M Nour

Critical review of the manuscript for important intellectual content:  Christie Swaminathan, Wei H. Toh, Hussameldin M Nour, Mirza Baig

Supervision:  Christie Swaminathan

References

  • 1.Getting it right first time: the national survey of surgical site infection rates in NHS trusts in England. Wong J, Ho C, Scott G, Machin JT, Briggs T. Ann R Coll Surg Engl. 2019;101:463–471. doi: 10.1308/rcsann.2019.0064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Agency UHS. Surgical site infections (SSI) surveillance: NHS hospitals in England. 2022. https://www.gov.uk/government/publications/surgical-site-infections-ssi-surveillance-nhs-hospitals-in-england p. 47.https://www.gov.uk/government/publications/surgical-site-infections-ssi-surveillance-nhs-hospitals-in-england
  • 3.Surgical site infection prevention: a review. Seidelman JL, Mantyh CR, Anderson DJ. JAMA. 2023;329:244–252. doi: 10.1001/jama.2022.24075. [DOI] [PubMed] [Google Scholar]
  • 4.Determining the worldwide epidemiology of surgical site infections after gastrointestinal resection surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 2) GlobalSurg Collaborative. BMJ Open. 2017;7:0. doi: 10.1136/bmjopen-2016-012150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Surgical site infection - a European perspective of incidence and economic burden. Leaper DJ, van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, Berger A. Int Wound J. 2004;1:247–273. doi: 10.1111/j.1742-4801.2004.00067.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.The impact of surgical site infection on hospitalisation, treatment costs, and health-related quality of life after vascular surgery. Totty JP, Moss JW, Barker E, Mealing SJ, Posnett JW, Chetter IC, Smith GE. Int Wound J. 2021;18:261–268. doi: 10.1111/iwj.13526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Centers for Disease Control and Prevention. Surgical site infection. [ Apr; 2023 ]. 2023. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
  • 8.Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Infect Control Hosp Epidemiol. 2011;32:101–114. doi: 10.1086/657912. [DOI] [PubMed] [Google Scholar]
  • 9.Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Infect Control Hosp Epidemiol. 1999;20:250–278. doi: 10.1086/501620. [DOI] [PubMed] [Google Scholar]
  • 10.Prevention of surgical site infections: a systematic review of cost analyses in the use of prophylactic antibiotics. Purba AK, Setiawan D, Bathoorn E, Postma MJ, Dik JH, Friedrich AW. Front Pharmacol. 2018;9:776. doi: 10.3389/fphar.2018.00776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.The effectiveness of sterile wound drapes in the prevention of surgical site infection in thoracic surgery. Karapınar K, Kocatürk Cİ. Biomed Res Int. 2019;2019:1438793. doi: 10.1155/2019/1438793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Intraoperative povidone-iodine irrigation for infection prevention. Goswami K, Austin MS. Arthroplast Today. 2019;5:306–308. doi: 10.1016/j.artd.2019.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review. Chundamala J, Wright JG. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386220/ Can J Surg. 2007;50:473–481. [PMC free article] [PubMed] [Google Scholar]
  • 14.Intraoperative incision irrigation with high-volume saline reduces surgical site infection for abdominal infections. Wang J, Lv W, Xu S, et al. Front Surg. 2022;9:927896. doi: 10.3389/fsurg.2022.927896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Extensive intraoperative lavage: the key maneuver in the treatment of severe peritonitis. Seiler CA, Balsiger BM, Feodorovici M, Baer HU, Büchler MW. Dig Surg. 1996;13:400–404. [Google Scholar]
  • 16.A randomized controlled trial on intra-abdominal irrigation during emergency trauma laparotomy; time for yet another paradigm shift. Mashbari H, Hemdi M, Chow KL, Doherty JC, Merlotti GJ, Salzman SL, Singares ES. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928265/ Bull Emerg Trauma. 2018;6:100–107. doi: 10.29252/beat-060203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Intra-operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta-analysis. Mueller TC, Loos M, Haller B, et al. Langenbecks Arch Surg. 2015;400:167–181. doi: 10.1007/s00423-015-1279-x. [DOI] [PubMed] [Google Scholar]
  • 18.Superiority trial comparing intraoperative wound irrigation with aqueous 10% povidone-iodine to saline for the purpose of reducing surgical site infection after elective gastrointestinal surgery: study protocol for a randomised controlled trial. Maemoto R, Noda H, Ichida K, et al. BMJ Open. 2021;11:0. doi: 10.1136/bmjopen-2021-051374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cochrane Training. Cochrane Handbook for Systematic Reviews of Interventions. [ May; 2023 ]. 2022. https://training.cochrane.org/handbook https://training.cochrane.org/handbook
  • 20.Cochrane Training. RevMan 5. 2022. https://training.cochrane.org/online-learning/core-software/revman https://training.cochrane.org/online-learning/core-software/revman
  • 21.Meta-analysis in clinical trials. DerSimonian R, Laird N. Control Clin Trials. 1986;7:177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  • 22.Methods for combining randomized clinical trials: strengths and limitations. Demets DL. Stat Med. 1987;6:341–350. doi: 10.1002/sim.4780060325. [DOI] [PubMed] [Google Scholar]
  • 23.Quantifying heterogeneity in a meta-analysis. Higgins JP, Thompson SG. Stat Med. 2002;21:1539–1558. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
  • 24.Egger M, Smith GD, Altman DG. Systematic reviews in health care : meta-analysis in context. New York, NY: Wiley; 2001. Systematic Reviews in Health Care: Meta‐Analysis in Context. [Google Scholar]
  • 25.Deeks JJ, Altman DG, Bradburn MJ. Systematic Reviews in Health Care. New York, NY: Wiley; 2001. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis; pp. 285–312. [Google Scholar]
  • 26.Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Control Clin Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  • 27.A method for assessing the quality of a randomized control trial. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. Control Clin Trials. 1981;2:31–49. doi: 10.1016/0197-2456(81)90056-8. [DOI] [PubMed] [Google Scholar]
  • 28.Development of a quality assessment scale for retrospective clinical studies in pediatric surgery. Rangel SJ, Kelsey J, Colby CE, Anderson J, Moss RL. J Pediatr Surg. 2003;38:390–396. doi: 10.1053/jpsu.2003.50114. [DOI] [PubMed] [Google Scholar]
  • 29.Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Baker DM, Jones JA, Nguyen-Van-Tam JS, et al. Br J Surg. 1994;81:1054–1056. doi: 10.1002/bjs.1800810743. [DOI] [PubMed] [Google Scholar]
  • 30.Can povidone-iodine solution be used safely in a spinal surgery? Chang FY, Chang MC, Wang ST, Yu WK, Liu CL, Chen TH. Eur Spine J. 2006;15:1005–1014. doi: 10.1007/s00586-005-0975-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Efficacy of dilute betadine solution irrigation in the prevention of postoperative infection of spinal surgery. Cheng MT, Chang MC, Wang ST, Yu WK, Liu CL, Chen TH. Spine (Phila Pa 1976) 2005;30:1689–1693. doi: 10.1097/01.brs.0000171907.60775.85. [DOI] [PubMed] [Google Scholar]
  • 32.Topical rifampicin versus povidone-iodine for the prevention of incisional surgical site infections following benign gynecologic surgery: a prospective, randomized, controlled trial. Karuserci ÖK, Sucu S, Özcan HÇ, Tepe NB, Uğur MG, Güneyligil T, Balat Ö. https://pubmed.ncbi.nlm.nih.gov/31524943/ New Microbiol. 2019;42:205–209. [PubMed] [Google Scholar]
  • 33.The role of normal saline irrigation versus povidone iodine of surgical wound in decreasing the rate of surgical site infection in perforated appendicitis. Kashtel HJ, Al-Azzawi AHM, Khalaf AM. Int J Surg Sci. 2020;4:169–171. [Google Scholar]
  • 34.Efficacy of antiseptics in the prevention of post-operative infections of the proximal femur, hip and pelvis regions in orthopedic pediatric patients. Analysis of the first results. (Article in Slovak) Kokavec M, Fristáková M. https://pubmed.ncbi.nlm.nih.gov/18454914/ Acta Chir Orthop Traumatol Cech. 2008;75:106–109. [PubMed] [Google Scholar]
  • 35.Combined topical povidone-iodine and systemic antibiotics in postappendicectomy wound sepsis. Lau WY, Fan ST, Chu KW, Yip WC, Chong KK, Wong KK. Br J Surg. 1986;73:958–960. doi: 10.1002/bjs.1800731205. [DOI] [PubMed] [Google Scholar]
  • 36.Aqueous povidone-iodine versus normal saline for intraoperative wound irrigation on the incidence of surgical site infection in clean-contaminated wounds after gastroenterological surgery: a single-institute, prospective, blinded-endpoint, randomized controlled trial. Maemoto R, Noda H, Ichida K, et al. Ann Surg. 2023;277:727–733. doi: 10.1097/SLA.0000000000005786. [DOI] [PubMed] [Google Scholar]
  • 37.Comparison of irrigation with povidone-iodine versus normal saline on wound infection after open appendectomy. Owais MA, Haider SA, Abbas S, Ahmed K, Ahmed S, Rajput A. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll. 2019;24:265–271. [Google Scholar]
  • 38.Povidone-iodine wound irrigation and wound sepsis. Rogers DM, Blouin GS, O'Leary JP. https://pubmed.ncbi.nlm.nih.gov/6635913/ Surg Gynecol Obstet. 1983;157:426–430. [PubMed] [Google Scholar]
  • 39.Irrigation of subcutaneous tissue with povidone-iodine solution for prevention of surgical wound infections. Sindelar WF, Mason GR. https://pubmed.ncbi.nlm.nih.gov/419426/ Surg Gynecol Obstet. 1979;148:227–231. [PubMed] [Google Scholar]
  • 40.Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intra-abdominal infectious complications. Sindelar WF, Brower ST, Merkel AB, Takesue EI. J Hosp Infect. 1985;6:103–114. doi: 10.1016/s0195-6701(85)80054-2. [DOI] [PubMed] [Google Scholar]
  • 41.Comparing the efficacy of povidone-iodine and normal saline in incisional wound irrigation to prevent superficial surgical site infection: a randomized clinical trial in gastric surgery. Zhao LY, Zhang WH, Liu K, et al. https://www.journalofhospitalinfection.com/article/S0195-6701(22)00336-X/fulltext. J Hosp Infect. 2023;131:99–106. doi: 10.1016/j.jhin.2022.10.005. [DOI] [PubMed] [Google Scholar]
  • 42.Systematic review and meta-analysis of randomized controlled trials evaluating prophylactic intra-operative wound irrigation for the prevention of surgical site infections. de Jonge SW, Boldingh QJ, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, Boermeester MA. Surg Infect (Larchmt) 2017;18:508–519. doi: 10.1089/sur.2016.272. [DOI] [PubMed] [Google Scholar]
  • 43.Effect of wound irrigation on the prevention of surgical site infections: a meta-analysis. Fu C, Meng L, Ma M, Li N, Zhang J. Int Wound J. 2022;19:1878–1886. doi: 10.1111/iwj.13794. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES